LIBYA – The Government of the United Kingdom has provided a medical emergency package worth up to £10 million (US$10.58 million) to boost emergency response activities for Libyan flood victims…
Read MoreTag: UK
British Premier contemplates banning cigarettes for the next generation following in the footsteps of New Zealand
UNITED KINGDOM — In a move to combat the scourge of cigarette smoking, British Prime Minister Rishi Sunak is exploring a set of innovative measures that could prevent the next…
Read MoreRoche under fire for failing to include essential drug information, potentially putting patient safety at risk
UNITED KINGDOM — In a recent development, pharmaceutical giant Roche has found itself in hot water for omitting crucial safety information from a webpage dedicated to one of its cancer…
Read MoreGSK’s Ojjaara wins FDA approval for myelofibrosis patients battling anaemia
UNITED KINGDOM — GSK’s myelofibrosis therapy, Ojjaara, also known as momelotinib, has received the coveted stamp of approval from the US Food and Drug Administration (FDA). This development marks a…
Read MoreXRP Healthcare mobile wallet launches to revolutionize digital asset management and healthcare access
UNITED KINGDOM — The XRP Healthcare team has unveiled the XRPH Mobile Wallet, a game-changing application available now on the App Store and Google Play. This cutting-edge mobile wallet is…
Read MoreEmirates Health Services signs collaboration agreement with HCA International Limited
UAE – The Emirates Health Services (EHS) has entered into a collaboration agreement with HCA International Limited to increase patient satisfaction and health outcomes in the United Arab Emirates. Emirates…
Read MoreNICE recommends Eli Lilly’s Mounjaro for treating type 2 diabetes in a turnaround decision
UNITED KINGDOM — In a surprising turn of events, the National Institute for Health and Care Excellence (NICE) has issued final draft guidance endorsing Eli Lilly’s Mounjaro (tirzepatide) as a…
Read MoreAstraZeneca and Verge forge AI partnership targeting rare neurological disorders
UNITED KINGDOM — AstraZeneca’s subsidiary, Alexion, has partnered with Verge Genomics, tapping into the power of artificial intelligence (AI) to revolutionize drug discovery for rare neurodegenerative and neuromuscular diseases. The…
Read MoreUK government to criminalize possession of laughing gas by year-end
UNITED KINGDOM — The UK government has announced plans to categorize nitrous oxide, commonly known as laughing gas or NOS, as a class C drug and make its possession illegal…
Read MoreGSK & other corporate leaders urge EU to slash greenhouse gas emissions by 90% by 2040
UNITED KINGDOM — British pharma giant GSK, alongside other corporate leaders, Coca-Cola, Unilever, and other influential members of the Corporate Leaders Group (CLG) Europe is urging the European Union (EU)…
Read More